Lung Cancer Trial, Not Yet Recruiting NCT07460440 Sponsor: University of Utah Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT07460440
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are 21 years of age or older.
  • People who have been diagnosed with lung cancer of any stage or type, OR people who have had at least one lung nodule found on a chest scan (such as a low-dose CT scan) within the past 180 days, where their doctor has recommended or planned a biopsy, surgery, radiation, or another procedure to further investigate the nodule within the next six months.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have been diagnosed with or treated for any other cancer in the past 6 months, with exceptions for certain cancers: non-melanoma skin cancer, cervical carcinoma in situ, or low-grade prostate cancer (Gleason score of 6 or below) that was treated locally.
  • People who have a history of lung cancer or cancer that spread to the lungs from another part of the body, and who received definitive treatment (surgery, medication, or radiation) for it within the past 2 years.
  • People who are currently receiving systemic treatments such as chemotherapy, immunotherapy, or targeted therapy, or who are currently receiving radiation therapy for lung cancer.
  • People who have already had surgery to remove part or all of a lung cancer.
  • People who have had an invasive procedure related to a lung nodule (such as a biopsy or surgery) within the past 3 months.
  • People who are unable to provide a blood sample.
  • People (in the control group) who have any active cancer or have been diagnosed with cancer in the past 6 months, with exceptions for non-melanoma skin cancer, cervical carcinoma in situ, or low-grade prostate cancer (Gleason score of 6 or below) treated locally.
  • People (in the control group) who have been treated for any cancer in the past 6 months, with the same exceptions listed above.
  • People (in the control group) who have been hospitalised or had surgery (other than minor procedures such as mole removal) within the past 8 weeks.
  • People (in the control group) who have kidney failure, defined as having a certain level of reduced kidney function (eGFR below 60 mL/min/1.73m²) or who are on dialysis (confirm with trial site).
  • People (in the control group) who have liver failure, which may be defined by conditions such as brain problems caused by liver disease, blood clotting issues, cirrhosis, or certain abnormal liver test results (confirm with trial site).
  • People (in the control group) who have advanced or end-stage heart failure, classified as ACC/AHA Stage C or Stage D (confirm with trial site).
  • People (in the control group) who have had a blood clot in a vein, a heart attack, or a stroke within the past 8 weeks.
  • People (in the control group) who are currently pregnant or have been pregnant within the past 12 weeks.
  • People (in the control group) who have received a blood transfusion within the past 8 weeks.
  • People (in the control group) who have ever had lung cancer at any point in their life.
  • People (in the control group) who are unable to provide a blood sample.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If this is close to home

This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.

  • Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
  • Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
  • Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
  • Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
  • Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14

Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.

Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Principal Investigator: Shiven Patel, MD/MBA, University of Utah

Phone: 801-587-8308

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Sensitivity; Specificity; Positive predictive value (PPV); Negative Predictive Value (NPV)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov